Bionano Genomics (BNGO) Assets Average (2018 - 2026)

Bionano Genomics (BNGO) has 9 years of Assets Average data on file, last reported at $69.2 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 10.77% year-over-year to $69.2 million; the trailing twelve-month figure through Mar 2026 stood at $69.2 million (down 10.77% YoY), and the FY2025 full-year result was $75.1 million, down 48.38% from the prior year.
• Assets Average declined to $69.2 million in Q1 2026, from $76.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $362.7 million in Q1 2022 to a low of $69.2 million in Q1 2026.
• A 5-year average of $190.6 million and a median of $186.2 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average surged 62.88% in 2022 and tumbled 58.61% in 2024, its largest moves.
• Tracing BNGO's Assets Average over 5 years: stood at $315.6 million in 2022, then slumped by 37.21% to $198.2 million in 2023, then sank by 58.61% to $82.0 million in 2024, then dropped by 6.94% to $76.3 million in 2025, then declined by 9.34% to $69.2 million in 2026.
• Business Quant data shows BNGO's Assets Average at $69.2 million in Q1 2026, $76.3 million in Q4 2025, and $77.5 million in Q3 2025.